Ralf Kuriyel, Senior VP, R&D at REPLIGEN CORP (RGEN), sold 8,002 shares at $282.13 ($2.3M) on 2021-08-30, disclosed to the SEC on 2021-09-02.
Open-market sale of $2.3M RGEN by Senior VP, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $282.13 | 4,001 | $1.1M | 50.0% |
| 2 | $282.13 | 4,001 | $1.1M | 50.0% |
| Total | $282.13 avg | 8,002 | $2.3M | 100% |
| Filing → |
| RGEN | SELL | 2024-03-12 | $1.4M | — | Filing → |
| RGEN | SELL | 2022-08-12 | $2.3M | — | Filing → |
| RGEN | SELL | 2021-06-14 | $2.6M | — | Filing → |